Cephalomannine
CAS No. 71610-00-9
Cephalomannine( NSC 318735 | NSC 318735 | NSC318735 | Cephalomannine, taxol B )
Catalog No. M15736 CAS No. 71610-00-9
A taxol derivative with antitumor, antiproliferative properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 80 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 318 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCephalomannine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA taxol derivative with antitumor, antiproliferative properties.
-
DescriptionA taxol derivative with antitumor, antiproliferative properties.Chemotherapeutic Agents Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 318735 | NSC 318735 | NSC318735 | Cephalomannine, taxol B
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorOthers
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number71610-00-9
-
Formula Weight831.9006
-
Molecular FormulaC45H53NO14
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILES[H][C@@]1([C@@H]([C@@](C2(C)C)(C[C@@H](C(C)=C2[C@H](C([C@]([C@H](C[C@]34[H])O)1C)=O)OC(C)=O)OC([C@@H]([C@H](C5=CC=CC=C5)NC(/C(C)=C/C)=O)O)=O)O)OC(C6=CC=CC=C6)=O)[C@@]3(CO4)OC(C)=O
-
Chemical NameBenzenepropanoic acid, α-hydroxy-β-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Helson L. Int J Oncol. 1993 Feb;2(2):297-9.
2. Riondel J, et al. Anticancer Res. 1988 May-Jun;8(3):387-90.
3. Distefano M, et al. Anticancer Drug Des. 1998 Jul;13(5):489-99.
molnova catalog
related products
-
DM1-SMe
DM1-SMe is a potent inhibitor of maytansinoid microtubular. DM1-SMe is about 3 to 10-fold more potent than the parent drug Maytansine, with IC50s of 0.003 to 0.01 nM for DM1-SMe in a panel of human tumor cell lines.
-
Albendazole
Albendazole is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations.
-
Rauwolscine hydrochl...
Rauwolscine, a natural alkaloid, is a specific and reversible α2-adrenergic receptor antagonist (Ki: 12 nM).
Cart
sales@molnova.com